Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inverness Graham is a lower middle-market private equity firm headquartered in Newtown Square, Pennsylvania, with a dedicated focus on high-growth, technology-enabled businesses. The firm maintains a significant investment vertical in healthcare and life sciences, targeting companies that provide essential services, specialized manufacturing, and software solutions. Their investment strategy centers on a Buy-and-Build approach, where they partner with founder-led businesses to scale operations through organic growth and strategic add-on acquisitions. Notable areas of interest within healthcare include clinical trial services, life science tools, and medical technology components. By leveraging deep sector expertise, Inverness Graham aims to transform niche market leaders into larger, more diversified platforms. The firm typically targets companies with EBITDA between 3 million and 15 million dollars.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inverness Graham.